Full Title
PRO-ACTIVE: Comparing the Effectiveness of Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck CancerPurpose
Radiation therapy is a common part of treatment for head and neck cancers, but it can cause trouble swallowing (dysphagia). In this study, researchers are comparing the effectiveness of PRO-ACTIVE and RE-ACTIVE swallowing therapies. PRO-ACTIVE therapy is started before a person develops dysphagia, while RE-ACTIVE therapy is started after dysphagia develops.
Patients in this study will be randomly assigned to one of three groups:
- RE-ACTIVE therapy that involves both eating and swallowing exercises
- Low-intensity PRO-ACTIVE therapy that focuses on only on eating exercises to keep the swallowing muscles active
- High-intensity PRO-ACTIVE therapy that involves both eating and swallowing exercises
Who Can Join
To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have head and neck cancer and be planning to receive radiation therapy.
- Patients may not have previously received swallowing therapy for the current head and neck cancer, nor may they have metastatic cancer.
- This study is for patients age 18 and older.
For more information about this study, please contact Dr. Jennifer Cracchiolo at 212-639-8420.
Protocol
20-155
Disease Status
Newly Diagnosed & Relapsed/Refractory
Investigator
Co-Investigators
Louise Cunningham
Diseases
ClinicalTrials.gov ID
NCT03455608